Programme

  1. Coffee and registration

    Claudio Mereu Moderator: Claudio Mereu
    EU Regulatory Partner, Joint Managing Partner, Fieldfisher LLP, Belgium
  2. Keynote  Keynote

    Andrej Kobe Andrej Kobe
    DG Environment, Unit B.2 – Sustainable Chemicals, EU Commission, Belgium
  3. ECHA overview of REACH substance evaluation

    Claudio Carlon Claudio Carlon
    Head of Unit – Hazard Assessment C3, European Chemicals Agency, Finland
  4. Session 1: The identification of substances for evaluation
  5. MS perspective: Drivers for national priority substances

    Netherlands National Institute for Public Health and the Environment, The Netherlands, tbc

  6. Industry case study: How to address a listing of your substance proactively

    Jonathan Crozier Jonathan Crozier
    Secretary General, Formacare, Sector Group of Cefic, Belgium
  7. Q&A and panel discussion:

    • How we can further enhance cooperation between between stakeholders at an early stage or even prior to a listing?
    • Are the right substances being identified?
    • Are companies able to prepare with sufficient notice and transparency? Could MS and ECHA be more transparent about their choice of substances?
    • Is the process sufficiently predictable?
    • How to decide on the availability of substitutes
  8. Refreshments and networking

  9. Session 2: The substance evaluation process and context
  10. MS perspective: Process, case studies and strategies

    Christian Unkelbach Christian Unkelbach
    Scientific Officer, Federal Institute for Occupational Health and Safety, Germany
  11. Industry experience with first combined compliance check

    • Substance evaluation approach on Antimony as pilot case that could define the model for the future of ECHA’s combined evaluation, including grouping if substances and involving DUs for exposure info
    Caroline Braibant Caroline Braibant
    Secretary-General, International Antimony Association, Belgium
  12. Concerns about animal testing for substance evaluations

    Emma Grange Emma Grange
    Senior Science Advisor - Regulatory Toxicology, Cruelty Free International, UK
  13. Q&A

  14. Lunch

  15. Panel discussion:

    • How to optimise the Reach process with regards to substance and dossier evaluation?
    • What are the lessons learned/what can be improved?
    • Is the process sufficiently predictable?
    • Best practice in the relationships between substance evaluation stakeholders


    Moderator: Leena Ylä-Mononen, Director General for Environmental Protection and Ministry of Environment, Finland, tbc

  16. Session 3: Issues related to and consequences of substance evaluation decisions and conclusions
  17. Regulatory follow-up to substance evaluation decisions and conclusions

    Michel Franz Michel Franz
    REACH policy officer, Ministry for an ecological and solidary transition, France
  18. REACH substance evaluation failures

    Elise Vitali Elise Vitali
    Project Officer for Chemicals, European Environmental Bureau, Belgium
  19. Lessons drawn from case studies of well-managed substance evaluations

    Cefic member, tbc

  20. The enforcement of substance evaluation decisions/conclusions

    Otilija Špūrienė Otilija Špūrienė
    Chemical Substances Division, Senior Advisor, Environmental Protection Agency, Lithuania
  21. ECHA’s Board of Appeal decisions on substance evaluations

    ECHA Board of Appeal, Finland

  22. Challenging substance evaluation decisions before ECHA's Board of Appeal

    Claudio Mereu Claudio Mereu
    EU Regulatory Partner, Joint Managing Partner, Fieldfisher LLP, Belgium
  23. Q&A and panel discussion: The evolution of substance evaluation

    • How lessons learned from substance evaluations can inform future work
    • International dimension – what can we learn from global substance evaluation outcomes in the context of the SDG goals, substitution, and UN conventions?
  24. End of conference